NASDAQ:GMVD

G Medical Innovations (GMVD) Stock Forecast, Price & News

$0.40

-0.01 (-2.24%)

(As of 10:56 AM ET)

Compare

Today's Range: $0.39
▼
$0.41
50-Day Range: $0.37
▼
$2.69
52-Week Range: $0.34
▼
$41.30

Volume: 71,981 shs
Average Volume: 997,023 shs
Market Capitalization: $785,372.00

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About G Medical Innovations (NASDAQ:GMVD) Stock

G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously for up to 14 days. It also develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. The company was incorporated in 2014 and is based in Rehovot, Israel.

Receive GMVD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for G Medical Innovations and its competitors with MarketBeat's FREE daily newsletter.

GMVD Stock News Headlines

May 19, 2023 | finance.yahoo.com

G Medical Innovations Holdings Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification

April 18, 2023 | finance.yahoo.com

G MEDICAL UPDATES ON PATIENT ENROLLMENT GROWTH FOR ITS HOME MONITORING SERVICES OF 194% FROM JANUARY THROUGH APRIL 2023, AS COMPARED TO THE SAME PERIOD IN 2022

June 1, 2023 | Edge On The Street (Ad)

Graphite versus Lithium - What Investors Should Know

Over 18 million EVs will be cruising U.S roads by 2030. And every one million EVs manufactured will require 82,000 tons of the metal graphite for their batteries. That's a total of 1,476,000 tons of graphite! Graphite is actually the largest component of EV batteries - NOT lithium. Experts warn of a massive graphite shortfall, especially since North America currently has no operating graphite mines.

April 7, 2023 | americanbankingnews.com

Insider Selling: G Medical Innovations Holdings Ltd (NASDAQ:GMVD) Major Shareholder Sells 437,500 Shares of Stock

April 6, 2023 | americanbankingnews.com

Awm Investment Company, Inc. Sells 300,000 Shares of G Medical Innovations Holdings Ltd (NASDAQ:GMVD) Stock

April 4, 2023 | finance.yahoo.com

G Medical Innovations Holdings Ltd. Announces Closing of Public Offering

April 2, 2023 | nasdaq.com

G Medical Innovations Falls 43% After Announcing Pricing Of 12 Mln Public Offering

March 31, 2023 | finance.yahoo.com

G Medical Innovations Holdings Ltd. Announces Pricing of Public Offering

June 1, 2023 | Edge On The Street (Ad)

Graphite versus Lithium - What Investors Should Know

March 29, 2023 | finance.yahoo.com

G MEDICAL INNOVATIONS AND ADVENTHEALTH IN JOINT COLLABORATION TO PROVIDE INNOVATIVE REMOTE PATIENT MONITORING SOLUTIONS FOR ADVENTHEALTH PATIENTS IN CENTRAL FLORIDA

March 27, 2023 | msn.com

G Medical Innovations, MiCare Path sign collaboration agreement for their solutions

February 18, 2023 | finance.yahoo.com

G Medical Innovations Holdings Ltd Announces Nasdaq Staff Listing Determination; Plans to Request Hearing

February 13, 2023 | finance.yahoo.com

G Medical Innovations announces receipt of patent from USPTO for vital signs sensors

January 30, 2023 | benzinga.com

What's Going On With G Medical Innovations Stock Today?

January 30, 2023 | marketwatch.com

G Medical Innovations Gets Notice of Patent Issuance For Vital Signs Sensors

January 30, 2023 | finance.yahoo.com

G Medical Innovations announces receiving notice of patent issuance from the USPTO for vital signs sensors

January 11, 2023 | benzinga.com

G Medical Innovations Holdings Shares Halted On Circuit Breaker To The Upside, Stock Now Up 98.6%

January 11, 2023 | benzinga.com

G Medical Innovations Holdings Shares Resume Trade Following Circuit Breaker Halt, Stock Now Up 105%

January 11, 2023 | marketwatch.com

G Medical Innovations Up 83% on Heavy Volume

December 5, 2022 | finance.yahoo.com

G Medical Innovations to announce receiving of 2 (two) granted patents from the USPTO for its Prizma care and other physiological sensors developed by the company.

November 22, 2022 | finance.yahoo.com

G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) Announces Receipt of Notice of Deficiency with Nasdaq Continued Listing Requirements

October 7, 2022 | benzinga.com

Security Innovation offers free, hands-on software security training

October 6, 2022 | finance.yahoo.com

G Medical Innovations is introducing a Monkeypox consumer home health test kit, along with 30 new direct to consumer home health testing kits with 24 to 48 hours results

August 9, 2022 | benzinga.com

Medical Marijuana Market Worth USD 248.42 Billion by 2030 at 31.97% CAGR - Report by Market Research Future (MRFR)

June 17, 2022 | seekingalpha.com

Nasdaq sends non-compliance notice to G Medical Innovations Holdings

May 21, 2022 | benzinga.com

G Medical Innovations (NASDAQ:GMVD), Earnings Estimates, EPS, and Revenue

May 20, 2022 | seekingalpha.com

G Medical Innovations announces $1M buyback program

See More Headlines

GMVD Price History

30 days | 90 days | 365 days | Advanced Chart

GMVD Company Calendar

Today: 6/01/2023
Next Earnings (Estimated): 8/15/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:GMVD
CUSIP: N/A
CIK: 1760764
Web: gmedinnovations.com
Phone: 972-8958-4777
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.22
Quick Ratio: 0.19

Sales & Book Value

Annual Sales: $4.42 million
Price / Sales: 0.17
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($3.21) per share
Price / Book: -0.12

Miscellaneous

Outstanding Shares: 1,960,000
Free Float: 1,235,000
Market Cap: $764,596.00
Optionable: Not Optionable
Beta: N/A

Key Executives

Dr. Yacov Geva (Age 72)
Pres, CEO, MD & Exec. Director
Comp: $360k

Mr. Igor Bluvstein
Chief Financial Officer

Mr. Benny Tal (Age 63)
VP of R&D and CTO

Mr. Oded Shahar (Age 62)
Sr. Investment Banker and Sr. VP of Merger & Acquisition

Ms. Dror Nuriel-Roth (Age 47)
Exec. VP of US Operations

Mr. Kobi Ben Efraim (Age 67)
Controller

Mr. Brett Tucker
Company Sec.

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

GMVD Stock - Frequently Asked Questions

How have GMVD shares performed in 2023?: G Medical Innovations' stock was trading at $3.28 on January 1st, 2023. Since then, GMVD shares have decreased by 88.1% and is now trading at $0.3901.
View the best growth stocks for 2023 here.
When is G Medical Innovations' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 15th 2023.
View our GMVD earnings forecast.
When did G Medical Innovations' stock split?: G Medical Innovations shares reverse split before market open on Saturday, November 19th 2022. The 1-35 reverse split was announced on Saturday, November 19th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Saturday, November 19th 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.
When did G Medical Innovations IPO?: (GMVD) raised $8 million in an IPO on Friday, June 25th 2021. The company issued 3,000,000 shares at a price of $5.00-$0.00 per share.

What is G Medical Innovations' stock symbol?: G Medical Innovations trades on the NASDAQ under the ticker symbol "GMVD."
Who are G Medical Innovations' major shareholders?: G Medical Innovations' stock is owned by a number of institutional and retail investors. Top institutional investors include Sabby Management LLC (68.74%), Perkins Capital Management Inc. (10.20%) and Barclays PLC (2.85%).
View institutional ownership trends.
How do I buy shares of G Medical Innovations?: Shares of GMVD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is G Medical Innovations' stock price today?: One share of GMVD stock can currently be purchased for approximately $0.39.
How much money does G Medical Innovations make?: G Medical Innovations (NASDAQ:GMVD) has a market capitalization of $764,596.00 and generates $4.42 million in revenue each year.
How can I contact G Medical Innovations?: G Medical Innovations' mailing address is 5 OPPENHEIMER ST., REHOVOT L3, 7670105. The official website for the company is gmedinnovations.com. The company can be reached via phone at 972-8958-4777.

This page (NASDAQ:GMVD) was last updated on 6/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial